Objective: To establish and compare the onset and duration of action of 2 local anesthetics based on objective lameness and skin sensitivity assessment.
| I NT ROD UCTI ON
Palmar digital nerve blocks (PDNB) are used to screen for pain in the foot but it lacks the ability to localize the exact origin of pain. 1, 2 Resolution of lameness after PDNB can be attributed to sole pain, 3 but pain may also arise from other structures such as the distal interphalangeal joint, 4 the navicular bone and bursa, 5 or in some circumstances even the proximal interphalangeal joint 6, 7 and metacarpophalangeal joint. 1, 8 For this reason, a short local anesthetic action is beneficial when subsequent, more precise localization is to be attempted. Conversely, a prolonged action is desirable when more than one source of pain is expected in the ipsilateral limb or if multiple limb lameness is present. 2 Uncertain persistence or diminishment of the PDNB can additionally affect planning of successive blocks. Consequently, the local anesthetic agent chosen can affect the efficacy and accuracy of a lameness investigation. 9 Mepivacaine and lidocaine are used for diagnostic perineural anesthesia in lameness investigations. 2, 10 Both are commercially available in most parts of the world for use in horses in 2% solutions. 2, 3, [9] [10] [11] [12] Both agents are considered to have a fast onset and an intermediate duration 13 but their reported efficacies vary. 2 The duration of action of mepivacaine range from 90-120 14 to 120-180 minutes. 13, 15 Information on the duration of action of local anesthetics is commonly based on interspecies extrapolation and subjective assessments of skin sensitivity or lameness. 9 The subjective interpretation of responses to diagnostic local anesthesia introduces bias in lameness investigations 16 and the general reliability and repeatability of subjective lameness evaluation has been challenged. 17, 18 Objective lameness assessment with inertial sensor systems removes bias in lameness investigations 1, 19 and can be used to objectively interpret the response to diagnostic local anesthesia in the foot. 20 Skin sensitivity testing can further introduce bias, 10 since the absence of a nocifensive response (ie, withdrawal) to pressure application over the heels assumes effectiveness of a PDNB. 2, 15 Objective data comparing skin sensitivity testing and lameness after perineural anesthesia are lacking, and the relationship between the onset and duration of skin desensitization and the onset and duration of lameness resolution remains unclear. The objective of this study was to establish and compare the onset and duration of action of 2 local anesthetics based on objective lameness and skin sensitivity assessment. We hypothesized that lidocaine would have a shorter duration of action than mepivacaine.
9,14 Furthermore, we hypothesized that both anesthetics would have a disparity in the time to return of skin sensitivity and return of lameness.
| M ATE RI ALS AN D ME THO DS

| Study design
An interventional crossover, cohort study design with randomization of treatments was used to test the hypotheses.
| Horses
The Institutional Animal Research Ethics Committee approved this study. Eight mature horses with a mean age of 10 years (median 11 years, range, 4-13 years) and a mean weight of 495 kg (median 491, range, 433-557 kg), consisting of 4 Standardbreds and 4 Thoroughbreds and including 2 mares and 6 geldings were selected from the institutional herd. Inclusion required the lack of detectable lameness when trotted in a straight line as assessed subjectively and objectively with a body-mounted inertial sensor system (Lameness Locator, Equinosis LLC, Columbia, MO).
| Model of lameness induction
The forefeet of the horses were shod with modified horseshoes, based on previously described models. 21, 22 Lameness was temporarily induced by application of sole pressure with a 10 mm diameter, blunt-ended, headless set screw ( Figure 1 ). Pressure application was localized to the lateral angle of the sole. Screw tightness was adjusted to vary the degree of lameness. The position of the screws was marked to allow for detection of any potential loosening of the screw during the trials. Screw removal resulted in resolution of lameness.
| Lameness assessment
Objective lameness evaluation was performed with an inertial sensor system, consisting of a body-mounted gyroscope and 2 accelerometers, as described previously. 20, [23] [24] [25] Briefly, the accelerometers were secured to the center of the poll and the dorsal midline at the level of the sacral tuberosity, and the gyroscope to the dorsal surface of the right fore pastern. These sensors enable detection of head and pelvic movement asymmetries during motion. 23 All lameness data were collected at the trot on a straight line on the same firm turf surface track. The track, clinically used for lameness investigations, was surfaced with thin grass and a light layer of wood shavings. Regular mechanical compacting ensured that a firm surface was maintained. Horses were trotted in hand on a loose lead rope. Two assessments at the trot were collected at each time point. Each assessment consisted of a minimum of 25 strides with a stride rate variation of less than 15% between assessments. For the purpose of this study, only forelimb data were considered for analysis. The inertial sensor system identifies forelimb lameness by pattern analysis of vertical head movement in association with the angular velocity of the right forelimb. 23, 26, 27 Processing and analysis of the inertial sensor data were performed via computerized motion analysis algorithms, as detailed elsewhere. 23, 27 The computer-based output included the mean and standard deviation (SD) of the maximum (DiffMaxHead) and minimum (DiffMinHead) height difference of the head when comparing the right and left forelimb before the weight bearing phase (DiffMaxHead) and during the mid-stance phase (DiffMinHead) of the stride, and the resulting vector sum (VS). The latter is the square root of the sum of the squared DiffMaxHead and DiffMinHead and has been shown to have a 95% confidence interval (CI) of 8.5 mm.
23
A vector sum of 0 is consistent with perfect symmetry and grade 0 lameness based on the American Association of Equine Practitioners (AAEP) 28 scale. 23, 27 An increase in vector sum indicates increasing gait asymmetry. 23 Natural gait asymmetry or "laterality" has been documented. 29 Based on a test-retest, 95% confidence interval of close to 6 mm for DiffMaxHead and DiffMinHead, 23 an increase in vector sum of greater than 8.5 mm should be considered a pathologic asymmetry and presence of lameness. This is also the recommended threshold for lameness detection by the manufacturer. 30 Therefore, presence of consistent forelimb lameness was conditional to (1) a vector sum of more than 8.5 mm, (2) a mean DiffMaxHead and or DiffMinHead above the threshold (66 mm) for the respective leg in combination with (3) a SD of lesser value than the absolute value of the mean of DiffMinHead. 23 In contrast to previous descriptions, 19 ,31 the a1/a2 ratio has been replaced by the more reliable 27 vector sum as a threshold for forelimb lameness detection. The magnitude of the vector sum was used as the quantitative measurement for the degree of lameness 23, 27 and its percentage change over time was determined.
| Skin sensitivity assessment
Evaluation of skin desensitization was performed with a force gauge (EFG200, S.I. Instruments, Adelaide, Australia).
Pressure was applied over the medial and lateral heel bulbs and their peak mechanical nociceptive thresholds (MNTs) were measured in Newtons (N), as previously described.
11
Based on safety recommendations 2 and the author's own clinical approach, the limb to be tested was held off the ground and a ballpoint pen-like attachment ( Figure 2 ) was used to apply pressure until a withdrawal response occurred. No more than 65 N were applied, since a greater force resulted in skin injuries and was considered higher than that used in a clinical setting. Three measurements per heel bulb of the treated and the contralateral (control) limb were taken at each time point. The same operator performed all measurements (MH). Heel bulb and leg to be tested were alternated to reduce adaptation of responses. The mean of the measurements (N) per heel bulb per time point was calculated and the means of the corresponding heel bulbs of the contralateral limbs were compared. Categorization of absent, partial, or complete desensitization was based on the magnitude of difference between mean MNTs of the heel bulbs of the 2 limbs, as previously described. 11 The categorization was modified from the previous description 11 since a pointed, ballpoint pen-like attachment was used here, which reduced the maximal applicable force and therefore lead to lower MNTs. Complete desensitization was defined as a MNT of greater than 3 times the value of the corresponding heel bulb of the contralateral limb (control) and an absent withdrawal reflex. Partial desensitization was defined as a MNT of 2-3 times the value of the control, and absent desensitization of skin as a MNT of less than 2 times the control value.
| Pilot study to verify lameness model
A pilot study was performed to assess the reliability of the model to induce lameness over a prolonged period of time and rule out conditioning of the horses to the model. Six horses were enrolled in the pilot study. A moderate degree of unilateral forelimb lameness was induced by application of sole pressure. The lameness was quantified and its consistency assessed with the inertial sensor system, as described above. The aim of induction was a vector sum of greater than 60 mm and 2 consecutive assessments at the trot with less than 10% difference in vector sum. The resulting lameness was subjectively consistently observable at the trot but not the walk (grade 3/5 AAEP scale). Two assessments at the trot were performed every 15 minutes. For each time point, the mean vector sum of the 2 assessments was determined and compared to the mean vector sum at the time of lameness induction. The percentage change in vector sum over time was determined until one of the following 2 endpoints was reached. Testing was discontinued when either the mean vector sums at 2 consecutive time points were over 1.5 times the value of the originally induced lameness regardless of the duration of testing, or if this did not occur, the mean vector sums at 3 consecutive time points were within a 10% range of each other after a minimum testing period of 180 minutes. This pilot study was performed no closer than 5 days to the experimental trials.
| Main study protocol
Mepivacaine or lidocaine PDNBs were assigned by randomization of the leg (left or right forelimb) and treatment (mepivacaine or lidocaine). The 4 combinations of limb and treatment were determined and duplicated, then randomly assigned to each of the 8 horses for the first trial by draw. For the second trial, limb and treatment were crossed over and the default combination assigned to each horse. There was a minimum washout period of 4 days between experimental trials. Prior to PDNB, the horses were subjectively and objectively assessed to ensure absence of lameness. In line with the description of the pilot study, unilateral forelimb lameness was subsequently induced by application of sole pressure and its consistency assessed and quantified with the inertial sensor system. The aim was a vector sum of greater than 60 mm and 2 consecutive assessments at the trot with less than 10% difference in vector sum. The resulting lameness was subjectively a grade 3/5 AAEP scale. A PDNB was then performed by inserting a 25 gauge, 5/8 inch, distally oriented needle at the proximal margin of the collateral cartilage directly over the palpable neurovascular bundle and 1.5 mL of the local anesthetic were deposited as far distally as possible over the medial and lateral palmar digital nerves. 2, 6, 7 The same operator applied all perineural blocks (RLS). Data collection commenced 10 minutes after nerve block application starting with skin sensitivity assessment, followed by lameness assessment via inertial sensor system, as detailed above. This was repeated at 15 minute intervals until skin sensitivity and lameness had returned completely. Data collection for skin sensitivity return was discontinued when the requirements for absent desensitization were met at 2 consecutive time points as specified above. Data collection for lameness was discontinued when the mean vector sum of the detected lameness was within 10% of the mean vector sum of the induced lameness.
| Data analysis
The times of lameness resolution/skin desensitization (T1), consistent lameness detection/partial return of skin sensitivity (T2), and complete return (T3) of lameness and skin sensitivity were determined. For lameness, T1 was conditional to a mean vector sum of less than 8.5 mm (grade 0/5 AAEP scale) and a lack of consistent lameness in the trial leg in both assessments at the trot (SD > DiffMinHead). T2 was defined as a mean vector sum greater than 8.5 mm, and at least one assessment at the trot with the presence of a consistent lameness in the trial leg (SD < DiffMinHead). T3 was reached when the mean vector sum was within 10% of the originally induced value and both assessments at the trot showed a consistent lameness in the trial leg (SD < DiffMinHead). For skin sensitivity, T1 was conditional to an increase greater than 3 times the mean MNT of the corresponding heel bulb of the control limb. T2 was defined as a mean MNT of greater than 2 but less than 3 times the value of the control heel bulb. T3 was reached when the difference in MNTs was less than 2 times the value of the control heel.
| Statistical analysis
The proportion of horses with outcomes, mean vector sum with range (in millimeter), the percentage change of the mean vector sum in relation to time (in minutes), and mean MNT with range (in N) are described. The percentage change in vector sum was further used to quantify reduction or increase in lameness (in %). The estimates of time to lameness resolution/skin desensitization (T1), consistent lameness detection/partial return of skin sensitivity (T2), and complete return (T3) of lameness and skin sensitivity are reported as mean (95% CI). Time was assumed to be continuous and was compared between treatments and across outcomes using paired t tests with significance determined at P .05. Normality assumptions were verified by examination of Q-Q plots of the differences. All data were analyzed using statistical software (SAS v9.4, SAS Institute, Cary, North Carolina).
| R ES ULT S
| Pilot study
A forelimb lameness fulfilling the above detailed consistency criteria was achieved and maintained throughout the trials in all 6/6 horses. Minor adjustments of the vector sum and consequently magnitude of lameness were detected but at no point was lameness in breach of the consistency criteria and 4/6 horses showed an increase in lameness over time. Despite the decrease in vector sum in 2/6 horses, lameness remained consistently detectable at the trot (grade 3/5 AAEP). The mean vector sum of the induced lameness was 70.04 mm (range, 59.75-85.95 mm). In 2/6 horses, data collection stopped at 75 and 90 minutes since these horses fulfilled the criteria for early discontinuation of the trials. Both horses showed a marked increase in lameness severity (>1.5 times increase of the induced mean vector sum) at 2 consecutive time points. In the remaining 4 horses, trials were continued until the lameness had plateaued (mean vector sum within 10% range) at 3 consecutive time points. For 2 horses, this occurred at 255 minutes and for the remaining 2 horses at 270 minutes. In these 4 horses, lameness at the time of discontinuation ranged from 72% to 137% of the mean vector sum of the induced lameness.
| Main study
| Lameness induction
A forelimb lameness fulfilling the above detailed consistency criteria was induced in 8/8 horses for both anesthetics. The mean vector sum of the induced lameness for mepivacaine was 79.98 mm (range, 61.75-100.9 mm) and for lidocaine 82.41 mm (range, 65.95-103.0 mm). The degree of induced lameness did not differ between the two anesthetics (P 5 .751).
| T1 (Table 1)
Mepivacaine resolved lameness in 8/8 horses. Lidocaine resolved lameness in only 3/8 horses, with the other 5/8 showing partial reduction only. Skin desensitization occurred in 8/8 horses for both anesthetics. For both anesthetics, the mean MNTs of the medial and lateral heel bulb did not differ at T1 (mepivacaine and lidocaine, P 5 1.0) and were averaged for the purpose of comparison. There was no difference in the time to skin desensitization for both anesthetics (P 5 1.0). For mepivacaine, skin desensitization occurred earlier than resolution of lameness (P 5 .047). The comparison at T1 for lidocaine was not performed due to incomplete lameness resolution in 5/8 horses and resulting small sample size.
For mepivacaine, 7/8 horses had complete skin desensitization in both heel bulbs at the 10 minute assessment. In 1/8 horses, a single heel bulb had remaining skin sensitivity but was subsequently completely desensitized at the 25 minute assessment. Skin desensitization for mepivacaine coincided with lameness resolution in 4/8 horses at the 10 minute assessment. In the remaining 4/8 horses, the reduction in lameness at the 10 minute assessment was 67%-84%. In these horses, the lameness gradually reduced further until complete resolution at the 40 to 85 minute assessment.
For lidocaine, in the 5/8 horses with only partially reduced lameness, the extent of reduction after the PDNB ranged from 54% to 81%. Skin desensitization had occurred in both heel bulbs in 8/8 horses at the 10 minute assessment. This coincided in 2/8 horses with lameness resolution. In 1/8 horses, the reduction in lameness at the 10 minute assessment was 84%, which reduced further until complete resolution at the 40 minute assessment.
The 
| T2 (Table 2)
Consistent lameness (T2) was detected later for mepivacaine than lidocaine (P < .001). Skin sensitivity for mepivacaine partially returned in 2/8 horses in both heel bulbs and in 4/8 horses in a single heel bulb. In lidocaine, a single heel bulb in 1/8 horses had partial skin sensitivity return. For the remaining horses, (2/8 horses for mepivacaine, and 7/8 horses for lidocaine) skin sensitivity returned completely without detection of prior partial return in any heel bulb. The comparison of skin sensitivity and assessment methods at T2 was not performed due to the small sample size for partial return of skin sensitivity. Immediate complete return of lameness (without prior detection of a consistent lameness of a lesser degree) occurred in 1/8 horses for mepivacaine and lidocaine, interestingly in the same horse. This horse fulfilled the T2 and T3 lameness criteria at the same time point. In the remaining 7/8 horses, the mean reduction in lameness at T2 was 51% (range, 24%-91%) for mepivacaine and 44% (range, 27%-88%) for lidocaine. The mean reduction in lameness at T2 did not differ between anesthetics (P 5 .890).
| T3 (Table 3)
Complete lameness and skin sensitivity (T3) returned later with mepivacaine than lidocaine (lameness P < .001, skin sensitivity P 5 .038). For both anesthetics, the mean MNTs of the medial and lateral heel bulbs did not differ at T3 (mepivacaine P 5 .785, lidocaine P 5 .111) and were averaged for the purpose of comparison. For lidocaine, but not for mepivacaine, skin sensitivity returned sooner than lameness at T3 (lidocaine P 5 .015, mepivacaine P 5 .115).
Regardless of the anesthetic, heel bulbs with initial partial return of skin sensitivity (T2) experienced full skin sensitivity return (T3) at the next assessment, 15 minutes later. T3 for lameness could not be determined in 1/8 horses for mepivacaine and 1/8 horses for lidocaine, since trials for these 2 horses ended prematurely due to weather conditions. The 2 affected trials ended after 475 and 220 minutes for mepivacaine and lidocaine, respectively. At those points in time, the lameness was reduced to 67% of its induced mean vector sum for both prematurely ended trials.
| D IS C US S I ON
The main finding of our study is that mepivacaine was superior to lidocaine at resolving an induced lameness after PDNB. Lidocaine improved, but did not resolve lameness in over half of the horses, despite complete skin desensitization. Residual lameness after lidocaine PDNBs was close to 50% of the induced lameness severity in some horses. Clinically, residual lameness could be misinterpreted as a negative response or evidence of a second source of lameness. 1 Another study 10 recently reported incomplete lameness resolution after lidocaine PDNB but in contrast to the present study, the majority of horses concurrently lacked skin desensitization. In this situation, the clinician would assume technical error and the block would be repeated. 1,2 A short-lived interval of complete lameness resolution for lidocaine between data collection time points cannot be excluded without continual assessment of lameness but the inability to predict and sustain lameness resolution for more than 10 to 15 minutes makes the usefulness of this local anesthetic for PDNBs in lameness investigations questionable. The inability of lidocaine to completely resolve lameness after a PDNB, despite skin desensitization, should be included as a reason for a false negative blocking response. Other authors 6 have reported incomplete resolution of lameness despite complete skin desensitization. Historically, the size principle assumed that pain conveying A-delta and C-fibers block simultaneously. 13 It has since been shown that sensory C-fibers were the least susceptible to impulse blockade by lidocaine. 32 Differences in nerve fiber susceptibility have been proposed as a more important determinant of differential neuronal blockade than pharmacokinetic factors. 32 Therefore, a higher susceptibility of pain conveying fibers to mepivacaine could explain its superiority in resolution of the induced lameness. Skin desensitization and resolution of lameness was achieved in all PDNBs with mepivacaine but there was a It is accepted that a nerve block should be assessed within 5-10 minutes after application due to its potential loss of specificity, 2, 15, 33 but there is controversy regarding the length of time to be granted prior to application of a subsequent block if the gait remains unchanged. 2, 15 The results of this study would suggest that a successive nerve block should not be applied if there is suspicion of even mild reduction in lameness after 10 minutes. If in doubt, a longer time between nerve blocks should be considered, although the potential for further diffusion needs to be taken into account.
In this study, the complete return of skin sensitivity and lameness was significantly disparate for lidocaine but not mepivacaine. This is in contrast to a previous study using mepivacaine, 9 which subjectively assessed skin desensitization via pinprick and found it persisted longer than objectively measured lameness. Contradicting results regarding the duration of skin desensitization and lameness resolution may be based on differences in study design or iatrogenic factors, but variations in differential neuronal blockade by different local anesthetics, different stimulation methods (sharp vs blunt pain) or variations in nerve compositions in different anatomic locations 32 all likely have an impact.
Mepivacaine had a significantly longer duration of action than lidocaine for skin sensitivity return and lameness resolution. Nevertheless, the time to baseline lameness return was highly variable for mepivacaine, ranging from 191 to 542 minutes, which is much longer than previously published (range, 90-180 minutes). 2, 13, 14 The use of mepivacaine for PDNB is therefore attractive for lameness investigation where concurrent foot pain is expected but not the only interest of the investigation. The time to detection of consistent lameness for mepivacaine with a mean of 169 minutes was longer than in a previous investigation by Bidwell et al, 9 which reported a partial return between 60 and 120 minutes after PDNB. Horses diagnosed with unilateral navicular syndrome were used in the later investigation and lameness was objectively assessed with a force plate. Discrepancies in results with the present study likely reflect differences in assessment methods. Additionally, the exact source of pain in the clinical cases was undiagnosed and lameness reduction was only partial in 5/10 horses, while the remaining horses showed previously undetected bilateral lameness. 9 An experimental model with controlled induction of lameness and crossover of treatments was chosen to reduce confounding factors and allow for isolation of a true treatment effect. Objective methods of lameness and skin sensitivity testing were utilized to further reduce bias. The inertial sensor system used in this study has been extensively validated. 19, 23, 27, 34 Recently, it has been used as a research tool for the quantification of lameness. 10, 24, 25, 31 Its usefulness in assessing a response to diagnostic local anesthesia has been proven. 20, 24 Objective assessment of skin sensitivity has been utilized by other authors. 11 The ballpoint pen-like attachment used in this study was chosen to mimic a clinical situation. 2, 15 Lameness induction by application of focal pressure to the sole has been reported as a reproducible and reversible way of lameness induction. 6, 21, 22 The ability of the model to maintain consistent lameness over a prolonged period of time was verified with the pilot study. This was important to exclude false-positive responses and to ensure the likelihood of return to baseline lameness. While the results might not be directly applicable to all sources or severities of pain in the foot, the model allowed for a homogenous pain induction in the study population. A consistent and obvious lameness was chosen, since this type of lameness lends itself to the use of diagnostic local anesthesia in a clinical setting. 1, 2 For extrapolation of the results to other perineural blocks, one should consider that differential neuronal blockade is likely to vary in different nerves due to variations in fiber composition. 32 Knowledge of the duration of action of a local anesthetic is necessary for effective decision-making in lameness investigation. Mepivacaine gives a more consistent and prolonged (greater than 2 hours) regional anesthesia when used in a PDNB, but successive intra-synovial blocks might have to be postponed until the next day due to the variable but often prolonged duration. Lidocaine, while shorter acting, is inconsistent in resolving lameness when used in PDNBs and its use for the purpose of lameness diagnosis should be reassessed. The practice of skin desensitization testing to indicate the onset of action or effectiveness of a PDNB for mepivacaine and lidocaine in lameness investigations should be carefully considered. Additionally, skin desensitization as a measure of the duration of action of lidocaine PDNBs should be interpreted with caution.
